Amphastar Pharmaceuticals, Inc.

NASDAQ:AMPH

21.21 (USD) • At close August 1, 2025
Bedrijfsnaam Amphastar Pharmaceuticals, Inc.
Symbool AMPH
Munteenheid USD
Prijs 21.21
Beurswaarde 999,820,311
Dividendpercentage 0%
52-weken bereik 20.385 - 53.96
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Dr. Yongfeng Zhang Ph.D.
Website https://www.amphastar.com

An error occurred while fetching data.

Over Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief

Vergelijkbare Aandelen

Bright Green Corporation logo

Bright Green Corporation

BGXX

0.038 USD

Relay Therapeutics, Inc. logo

Relay Therapeutics, Inc.

RLAY

3.36 USD

Definitive Healthcare Corp. logo

Definitive Healthcare Corp.

DH

3.74 USD

LumiraDx Limited logo

LumiraDx Limited

LMDX

0.016 USD

Schrödinger, Inc. logo

Schrödinger, Inc.

SDGR

19.53 USD

PROCEPT BioRobotics Corporation logo

PROCEPT BioRobotics Corporation

PRCT

49.96 USD

Myriad Genetics, Inc. logo

Myriad Genetics, Inc.

MYGN

3.91 USD

Ironwood Pharmaceuticals, Inc. logo

Ironwood Pharmaceuticals, Inc.

IRWD

0.771 USD

Sage Therapeutics, Inc. logo

Sage Therapeutics, Inc.

SAGE

8.68 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)